SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?


To: Sheldon C. who wrote (4036)12/6/1998 12:22:00 AM
From: David  Read Replies (1) | Respond to of 4676
 
Bob and Sheldon: I'm just trying to save you from any more heartbreak.

Here is a scenario that would scream, SELL!

Microsoft announces that Windows 2000 will be BioAPI compatible. (Microsoft is part of the BioAPI development alliance, so this is certainly a possibility.)

That means either (1) that all the SAF software won't run on next-generation MSFT operating systems (either at all or not without major revisions) or (2) it will be much easier in the upcoming development cycle to write applications to a BioAPI standard than the HAAPI standard in Windows 2000.

Either way, that means no one will develop applications using HAAPI, and the market for HAAPI-compatible software (i.e., NRID's present inventory) disappears, rendering the inventory worthless, since cross-media applications need a common API, and that will be BioAPI.

And since this HAAPI-based software is NRID's only asset . . . SELL.